http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9351956-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2c061f358588e346bc847500bc0fef0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95329fdbc2235070387b5ba1edbf11e1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385 |
| filingDate | 2013-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6eb1a3eb08d5ae4ef93a186b534df94 |
| publicationDate | 2016-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-9351956-B1 |
| titleOfInvention | Pharmaceutical composition comprising an enantiomer of lipoamide and derivatives thereof and method of use |
| abstract | This invention is directed to pharmaceutical compositions comprising substantially enantiomerically pure lipoamide and derivatives thereof and methods of use of such compositions to modulate signaling pathways for the treatment of diseases and disorders. |
| priorityDate | 2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 199.